Please take a look at these papers to learn more about the scientific evidence behind the benefits of this groundbreaking prostate cancer treatment.
€22m study funded by the French government>3,300 participants30 month follow upHIFU was non-inferior on cancer outcomesHIFU was superior on ED and incontinence
213 patients were enrolled in the study, randomised to focal ablation (FA) or radical prostatectomy (RP)Treatment failure was 5.6% in the FA arm vs 7.9% in the RP armStatistical difference of 2.3% in favour of focal ablation
If you are interested in supporting this project through an investment or otherwise, please get in touch with our founder, Graham Fulford MBE FCA, at grahamfulford47@gmail.com or 07831 156071.